반려동물 백신 세계 시장 규모는 2024년 113억 1,000만 달러로 평가되었습니다. 예측 기간 동안 161억 달러에 달할 것으로 예상되며, 2030년까지 연평균 6.04%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.
세계 반려동물 백신 시장은 반려동물 사육 증가와 동물 건강에 대한 인식이 높아지면서 큰 성장을 이루고 있습니다. 반려동물 사육 수가 계속 증가함에 따라 동물을 감염으로부터 보호하기 위해 백신 접종을 포함한 예방적 건강관리가 중요시되고 있습니다. 수의학의 발전으로 보다 효과적인 백신이 개발되어 광견병, 디스템퍼, 파보바이러스 등의 질병에 대한 예방 효과가 높아지고 있습니다. 수의학 서비스의 가용성이 확대되고, 진료소나 병원, 온라인 플랫폼을 통해 반려동물 백신에 대한 접근성이 향상되고 있는 것도 시장 확대에 기여하고 있습니다. 각 제조업체들은 효능이 강화되고 예방 기간이 길어진 차세대 백신을 도입하기 위해 연구개발에 투자하고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 113억 1,000만 달러 |
| 시장 규모 : 2030년 | 161억 달러 |
| CAGR : 2025-2030년 | 6.04% |
| 급성장 부문 | 비강 백신 |
| 최대 시장 | 북미 |
생명공학의 혁신과 DNA 백신과 재조합 백신의 등장으로 백신 시장의 판도가 바뀌고 있습니다. 각 업체들은 한 번의 접종으로 여러 질병에 대한 면역을 얻을 수 있는 혼합백신 개발에 집중하고 있으며, 동물병원 방문 빈도를 줄이고 반려동물의 순응도를 높이고 있습니다. 반려동물 백신, 특히 개와 고양이에 대한 수요가 증가하면서 시장 성장을 가속하고 있습니다. 동물 예방접종 프로그램을 장려하는 정부의 이니셔티브와 예방접종을 의무화하는 엄격한 규제가 시장 역학을 강화하고 있습니다. 예방접종 비용을 포함한 반려동물 보험의 보장 범위가 확대되면서 반려동물 소유주들이 예방적 건강관리에 대한 투자를 늘리고 있습니다. 가처분 소득 증가와 반려동물을 가족의 일원으로 여기는 반려동물의 인간화도 반려동물 백신 수요 증가에 기여하고 있습니다.
반려동물의 질병 유병률 증가
높은 백신 접종 비용
개인 맞춤형 반려동물 백신에 대한 수요 증가
Global Pet Vaccine Market was valued at USD 11.31 Billion in 2024 and is expected to reach USD 16.10 Billion in the forecast period with a CAGR of 6.04% through 2030. The global pet vaccine market is experiencing significant growth, driven by increasing pet adoption and rising awareness about animal health. As pet ownership continues to rise, there is a growing emphasis on preventive healthcare, including vaccination, to protect animals from infectious diseases. Veterinary healthcare advancements have led to the development of more effective vaccines, ensuring better protection against diseases such as rabies, distemper, and parvovirus. The expanding availability of veterinary services and improved access to pet vaccines through clinics, hospitals, and online platforms are further contributing to market expansion. Manufacturers are investing in research and development to introduce next-generation vaccines with enhanced efficacy and longer protection duration.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 11.31 Billion |
| Market Size 2030 | USD 16.10 Billion |
| CAGR 2025-2030 | 6.04% |
| Fastest Growing Segment | Intranasal Vaccines |
| Largest Market | North America |
Innovations in biotechnology and the rise of DNA and recombinant vaccines are transforming the market landscape. Companies are focusing on developing combination vaccines that provide immunity against multiple diseases with a single shot, reducing the frequency of veterinary visits and improving pet compliance. The rising demand for companion animal vaccines, particularly for dogs and cats, is fueling market growth. Government initiatives promoting animal vaccination programs and stringent regulations mandating immunization are strengthening market dynamics. The expansion of pet insurance coverage, which increasingly includes vaccination costs, is encouraging pet owners to invest in preventive healthcare. Increasing disposable income and the humanization of pets, where owners treat animals as family members, are also contributing to the growing demand for pet vaccines.
Key Market Drivers
Increasing Prevalence of Diseases in Companion Animals
The increasing prevalence of diseases in companion animals is a significant driver of the global pet vaccine market. In 2023, the World Health Organization (WHO) reported that rabies causes an estimated 59,000 human deaths annually, with dogs responsible for 99% of these transmissions. This alarming statistic underscores the critical need for effective vaccination programs to control rabies in canine populations, thereby protecting both animal and human health. Similarly, the WHO has highlighted concerns about psittacosis, a zoonotic disease transmitted from birds to humans. In February 2024, several European countries, including Austria, Denmark, Germany, Sweden, and the Netherlands, reported an increase in psittacosis cases observed in 2023 and early 2024, particularly since November-December 2023. These instances exemplify the rising incidence of zoonotic diseases, emphasizing the necessity for comprehensive vaccination strategies in companion animals.
Veterinary professionals and regulatory bodies are actively promoting routine vaccination schedules to curb the spread of these highly contagious diseases among pets. Government-led initiatives and vaccination mandates in several countries are reinforcing immunization practices, ensuring broader coverage among companion animals. For instance, the WHO recommends that vaccinating at least 70% of dogs in areas at risk is the most effective way of preventing human rabies deaths. This strategy not only safeguards animal health but also significantly reduces the risk of zoonotic disease transmission to humans. The increasing urbanization and closer human-animal interactions have raised concerns about zoonotic disease transmission, prompting pet owners to prioritize vaccinations as a preventive measure. In densely populated areas, the risk of disease outbreaks among pets is higher, making immunization an essential part of pet healthcare.
The increasing number of pet owners worldwide has been a driving force behind the expansion of veterinary healthcare facilities. For example, in countries such as the United States, over 90 million households now own pets, which has created a larger market for pet healthcare services. This surge in pet ownership has prompted veterinary clinics to expand their operations and offer more comprehensive healthcare solutions. At the same time, advancements in veterinary care, such as improved diagnostic tools and treatment options, have made it easier for clinics to provide effective care, including timely vaccinations for pets.
Government initiatives also play a crucial role in supporting the growth of veterinary healthcare infrastructure. Several countries have implemented programs to promote animal health and strengthen the veterinary workforce, including funding for veterinary clinics and training for veterinary professionals. This, in turn, ensures greater access to vaccines for pets and contributes to higher vaccination rates. As more pet owners seek professional care for their animals, the demand for dog vaccines continues to rise, further fueling the market's growth. Improved infrastructure and government support are creating a favorable environment for increased pet vaccination, thereby driving the expansion of the pet vaccine market.
Key Market Challenges
High Cost of Vaccination
One of the major challenges facing the global pet vaccine market is the high cost of vaccination, which can limit access to essential preventive healthcare for pets, particularly in lower-income regions. The price of vaccines varies depending on the type of vaccine, the brand, and the country in which they are administered. Vaccination costs are influenced by several factors, including the research and development expenses involved in creating new vaccines, regulatory fees, and distribution costs. For example, combination vaccines, which provide protection against multiple diseases in one dose, can be more expensive than single vaccines, further escalating the overall cost for pet owners.
In addition to the direct costs of vaccines, pet owners may incur additional charges for veterinary consultations and health assessments to determine which vaccines are needed for their dogs. This makes the vaccination process financially challenging for individuals, especially in regions where veterinary care is not subsidized or where pet healthcare is not covered by insurance. According to a report from the American Kennel Club, a basic vaccination package for a dog in the U.S. can cost anywhere from USD 75 to USD 150, depending on the vaccines included. More advanced vaccines or those for rare diseases may cost even more. These costs can be a significant burden for pet owners in developing countries or low-income households, potentially resulting in lower vaccination rates.
Key Market Trends
Increasing Demand for Personalized Pet Vaccines
The increasing demand for personalized pet vaccines represents a notable trend in the Pet Vaccine Market. This trend reflects a growing recognition that not all pets are alike, and tailoring vaccines to an individual animal's specific needs can yield significant benefits. Personalized pet vaccines involve customizing vaccination schedules and formulations based on factors such as a pet's age, breed, lifestyle, and geographic location. This approach ensures that each pet receives the most appropriate and effective protection against diseases, optimizing their overall health and minimizing unnecessary vaccinations. Advances in veterinary diagnostics, including genetic testing and serological assays, allow for a more precise understanding of a pet's immune status and susceptibility to specific diseases. This information can inform personalized vaccine recommendations. Pet owners increasingly view their pets as members of the family and are willing to invest in their well-being. They seek out veterinary practices that offer tailored healthcare plans, including personalized vaccines, to ensure the best outcomes for their pets.
Concerns about over-vaccination have led to a more selective approach to vaccinations. Personalization allows veterinarians to minimize unnecessary vaccinations, reducing the potential for adverse reactions and vaccine-related health issues. Regional disease prevalence varies, and some areas may have specific disease risks. Personalized vaccines can address these geographical variations, providing pets with targeted protection. In summary, the demand for personalized pet vaccines is driven by a shift toward individualized pet care and a desire to optimize vaccine effectiveness while minimizing risks. This trend aligns with the broader movement toward personalized medicine and is likely to continue shaping the Pet Vaccine Market in the coming years.
In this report, the Global Pet Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Pet Vaccine Market.
Global Pet Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: